共 262 条
[1]
Choudhury AD(2012)The role of genetic markers in the management of prostate cancer Eur Urol 62 577-587
[2]
Eeles R(2013)New insights into the management of renal cell cancer Oncology 84 22-31
[3]
Freedland SJ(2013)External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study Lancet Oncol 14 141-148
[4]
Isaacs WB(2008)Response assessment in solid tumours: a comparison of WHO, SWOG and RECIST guidelines Br J Radiol 81 444-449
[5]
Pomerantz MM(2009)New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) Eur J Cancer 45 228-247
[6]
Schalken JA(2014)Recommendations for the clinical and radiological evaluation of response to treatment in metastatic renal cell cancer Target Oncol 9 9-24
[7]
Tammela TL(2002)Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 20 289-296
[8]
Visakorpi T(2004)Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 22 454-463
[9]
Pecuchet N(2009)Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 27 5794-5799
[10]
Fournier LS(2012)Current status of targeted therapy for advanced renal cell carcinoma Korean J Urology 53 217-228